Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 18;26(10):e107-e109.
doi: 10.1093/ibd/izaa242.

Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Cristina Bezzio  1 , Lucienne Pellegrini  1 , Gianpiero Manes  1 , Ilaria Arena  1 , Desirée Picascia  1 , Cristina Della Corte  1 , Massimo Devani  1 , Mario Schettino  1 , Simone Saibeni  1
Affiliations
Comment

Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Cristina Bezzio et al. Inflamm Bowel Dis. .
No abstract available

Keywords: inflammatory bowel disease; COVID-19; Crohn disease; biologics; coronavirus; therapy; ulcerative colitis.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Feelings and behaviors of patients with IBD by study group. A, Responses to the 3 main questions (Fisher exact test). B, Causes of the perceived increased risk, by study group (χ 2 test).
See this image and copyright information in PMC

Comment on

References

    1. Axelrad JE, Malter L, Hong S, et al. . From the American epicenter: coronavirus disease 2019 in patients with inflammatory bowel disease in the New York City metropolitan area. Inflamm Bowel Dis. Accepted manuscript. Published online June 24, 2020. doi: 10.1093/ibd/izaa162. - DOI - PMC - PubMed
    1. Taxonera C, Sagastagoitia I, Alba C, et al. . 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52: 276–283. - PMC - PubMed
    1. Bezzio C, Saibeni S, Variola A, et al. ; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69:1213–1217. - PubMed
    1. Macaluso FS, Orlando A. Could patients with inflammatory bowel disease treated with immunomodulators or biologics be at lower risk for severe forms of COVID-19? Gastroenterology. Accepted manuscript. Published online ahead of print May 11, 2020. doi: 10.1053/j.gastro.2020.05.026. - DOI - PMC - PubMed
    1. Neurath MF. COVID-19 and immunomodulation in IBD. Gut. 2020;69:1335–1342. - PMC - PubMed